ODYSSEY Outcomes: High-risk Patients Benefit More From PCSK9s
Medscape,
Among ODYSSEY Outcomes participants, those with polyvascular disease or previous coronary artery bypass grafting (CABG) had a…
Among ODYSSEY Outcomes participants, those with polyvascular disease or previous coronary artery bypass grafting (CABG) had a…
Alirocumab reduced the risk for major adverse CV events and death in patients with recent ACS and polyvascular disease and in…
Patients at very high risk of adverse cardiovascular outcomes derive substantial benefit from proprotein convertase subtilisin/ke…
Despite the use of statin therapy, polyvascular disease has shown associations with increased risk for major adverse…